Functional Description
CJC-1295 (Without DAC) 5 mg + Ipamorelin 5 mg is a research peptide combination designed to investigate two complementary signaling pathways involved in growth hormone release and metabolic regulation.
CJC-1295 Without DAC is a short-acting GHRH analog that stimulates growth hormone-releasing hormone receptors, while Ipamorelin is a selective ghrelin receptor (GHS-R1a) agonist studied for its ability to promote growth hormone secretion through a separate pathway.
The combination is commonly used in research examining pulsatile GH signaling, IGF-1 pathways, protein synthesis, tissue recovery, body-composition mechanisms, and metabolic activity.
Key Research Functions:
Studied for growth hormone release and signaling
Investigated for GHRH + ghrelin receptor pathway interaction
Used in research involving pulsatile GH secretion
Studied for effects on IGF-1-related pathways
Investigated in protein synthesis and tissue-repair research
Used in metabolic and body-composition studies
Supports research into combined secretagogue activity
评价
目前还没有评价